₹1,480.8
▼ -8.79 -0.59%
17 Jul 2026
BSE Listed · Healthcare
Rainbow Childrens Medica (543524)
Volume: 2,165Avg Vol 1W: 34,197Avg Vol 1M: 34,06952W Range:₹1,008.75₹1,644.1
Key Ratios
Checked 3h agoMarket Cap₹15,040 Cr
Current Price₹1,480.8
Previous Close₹1,489.59
High / Low (52w)₹1,644.1 / ₹1,008.75
Volume2,165
Avg Vol (1W)34,197
Avg Vol (1M)34,069
Stock P/E60.79
Book Value₹164.36
Dividend Yield23%
ROE16.89%
ROA10.15%
Revenue (TTM)—
Revenue Growth16.88%
Profit Margin16.34%
Total Debt₹0 Cr
Shares Outstanding10 Cr
Face Value₹10
EPS (TTM)₹24.36
P/B9.01
Debt / Equity0.53
50 DMA₹1,389.89
200 DMA₹1,301.02
Day change-0.59%
Price Chart
₹1,480.8▼ 3.72% · 1Y
2025-07-172026-07-17
20-day avg volume: 37K shares
Pros
- Healthy return on equity of 16.9%.
- Pays a dividend yield of 23.0%.
- Company is almost debt-free.
- Revenue grew 11% YoY.
- Net profit is growing year over year.
Cons
- Stock trades at a high P/E of 61.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹330 Cr | ₹417 Cr | ₹398 Cr | ₹370 Cr | ₹353 Cr | ₹445 Cr | ₹445 Cr | ₹460 Cr |
| EBITDA | ₹72 Cr | ₹123 Cr | ₹112 Cr | ₹95 Cr | ₹89 Cr | ₹121 Cr | ₹118 Cr | ₹109 Cr |
| Net Profit | ₹40 Cr | ₹79 Cr | ₹69 Cr | ₹56 Cr | ₹54 Cr | ₹75 Cr | ₹73 Cr | ₹77 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹551 Cr | ₹730 Cr | ₹660 Cr | ₹993 Cr | ₹1,204 Cr | ₹1,334 Cr | ₹1,567 Cr | ₹1,747 Cr |
| EBITDA | ₹97 Cr | ₹138 Cr | ₹100 Cr | ₹241 Cr | ₹337 Cr | ₹354 Cr | ₹402 Cr | ₹437 Cr |
| Net Profit | ₹44 Cr | ₹55 Cr | ₹40 Cr | ₹138 Cr | ₹211 Cr | ₹217 Cr | ₹243 Cr | ₹278 Cr |
| EPS | 4.74 | 5.92 | 4.25 | 14.45 | 20.89 | 21.38 | 23.84 | 27.41 |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹926 Cr | ₹1,019 Cr | ₹1,081 Cr | ₹1,296 Cr | ₹1,776 Cr | ₹2,170 Cr | ₹2,377 Cr | ₹2,775 Cr |
| Total Liabilities | ₹554 Cr | ₹610 Cr | ₹633 Cr | ₹689 Cr | ₹711 Cr | ₹905 Cr | ₹902 Cr | ₹1,111 Cr |
| Equity | ₹372 Cr | ₹409 Cr | ₹448 Cr | ₹606 Cr | ₹1,065 Cr | ₹1,265 Cr | ₹1,475 Cr | ₹1,664 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹142 Cr | ₹191 Cr | ₹169 Cr | ₹286 Cr | ₹410 Cr | ₹410 Cr | ₹481 Cr | ₹521 Cr |
| Investing | ₹-117 Cr | ₹-117 Cr | ₹-83 Cr | ₹-175 Cr | ₹-465 Cr | ₹-226 Cr | ₹-268 Cr | ₹-259 Cr |
| Financing | ₹-9 Cr | ₹-52 Cr | ₹-61 Cr | ₹-44 Cr | ₹143 Cr | ₹-102 Cr | ₹-118 Cr | ₹-147 Cr |
| Free Cash Flow | ₹142 Cr | ₹191 Cr | ₹169 Cr | ₹286 Cr | ₹410 Cr | ₹410 Cr | ₹481 Cr | ₹521 Cr |
Shareholding
Promoter 49.84% Institutions 38.59% Public 11.57%
Efficiency & Working Capital
ROCE16.9%
Interest Coverage5.4
Dividend Payout—
Debtor Days22 d
Inventory Days9 d
Payable Days22 d
Cash Conversion Cycle9 d
Working Capital Days31 d
Shareholding Details
As of 2026-06-30
Promoter49.8%
FII16%
DII22.6%
Institutions38.6%
Public11.6%
Promoter Pledge0%
No. of Shareholders89,305
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 49.8% | 49.8% | 49.8% | 49.9% | 49.9% | 49.9% | 49.9% | 49.9% | 49.8% | 49.8% | 49.8% | 49.8% |
| FIIs | 21.6% | 22.3% | 24% | 24.8% | 25.1% | 25.1% | 23.7% | 23.6% | 21.9% | 19.2% | 17.2% | 16% |
| DIIs | 15.4% | 15.6% | 14.8% | 13.8% | 13.8% | 13.9% | 15.3% | 15.4% | 17.5% | 19.5% | 21.1% | 22.6% |
| Public | 13.1% | 12.2% | 11.4% | 11.5% | 11.2% | 11.2% | 11.1% | 11.1% | 10.8% | 11.4% | 11.8% | 11.6% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 79,187 | 80,471 | 77,152 | 78,557 | 77,524 | 78,764 | 79,092 | 80,320 | 81,134 | 88,809 | 88,561 | 89,305 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Ramesh Kancharla | Shareholding of Promoter and Promoter Group | 31% | 3.15 Cr |
| Chirla Dinesh Kumar Padmarao | Shareholding of Promoter and Promoter Group | 6.5% | 66,33,310 |
| Adarsh Kancharla | Shareholding of Promoter and Promoter Group | 6% | 61,10,432 |
| Icici Prudential Esg Exclusionary Strategy Fund | Public Shareholding | 6% | 60,70,842 |
| Ramesh Kancharla (kancharla Family Trust) | Shareholding of Promoter and Promoter Group | 5.1% | 52,05,700 |
| Dsp Nifty Smallcap 250 Etf | Public Shareholding | 4.1% | 41,57,196 |
| Franklin Templeton Investment Funds - Franklin Ind | Public Shareholding | 2.8% | 27,98,426 |
| Abu Dhabi Investment Authority - Monsoon | Public Shareholding | 2.1% | 21,59,233 |
| Hdfc Life Insurance Company Limited | Public Shareholding | 1.9% | 18,77,250 |
| Tata Mutual Fund - Tata Elss Fund | Public Shareholding | 1.7% | 16,90,480 |
| Axis Mutual Fund Trustee Limited A/c Axis Mutual F | Public Shareholding | 1.4% | 13,92,840 |
| Nippon Life India Trustee Ltd- A/c Nippon India Ag | Public Shareholding | 1.3% | 13,03,294 |
| Motilal Oswal Nifty Smallcap 250 Index Fund | Public Shareholding | 1.3% | 12,82,336 |
| Nagalakshmi Devineni | Public Shareholding | 1.2% | 12,03,009 |
| Ashoka Whiteoak Icav - Ashoka Whiteoak India Oppor | Public Shareholding | 1.1% | 10,95,355 |
| Podduturu Preetham Kumar | Public Shareholding | 1.1% | 10,82,900 |
| Chirla Padmarao Dinesh Kumar (sai Geeta Dinesh Trust) | Shareholding of Promoter and Promoter Group | 1% | 10,40,000 |
| Srinivas Talasila | Shareholding of Promoter and Promoter Group | 0.1% | 60,000 |
| Ramadhara Naidu K | Shareholding of Promoter and Promoter Group | 0.1% | 50,000 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Ramesh Kancharla | 0 | 0% | 2026-06-30 |
| Chirla Dinesh Kumar Padmarao | 0 | 0% | 2026-06-30 |
| Srinivas Talasila | 0 | 0% | 2026-06-30 |
| Ramadhara Naidu K | 0 | 0% | 2026-06-30 |
| Adarsh Kancharla | 0 | 0% | 2026-06-30 |
| Ramesh Kancharla (kancharla Family Trust) | 0 | 0% | 2026-06-30 |
| Chirla Padmarao Dinesh Kumar (sai Geeta Dinesh Trust) | 0 | 0% | 2026-06-30 |
| Icici Prudential Esg Exclusionary Strategy Fund | 0 | 0% | 2026-06-30 |
| Dsp Nifty Smallcap 250 Etf | 0 | 0% | 2026-06-30 |
| Nippon Life India Trustee Ltd- A/c Nippon India Ag | 0 | 0% | 2026-06-30 |
| Tata Mutual Fund - Tata Elss Fund | 0 | 0% | 2026-06-30 |
| Axis Mutual Fund Trustee Limited A/c Axis Mutual F | 0 | 0% | 2026-06-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Ramesh Kancharla | Chairman / Executive Director / M D / Promoter | 2026 |
| Dinesh Kumar Chirla | WTD & Executive Director | 2026 |
| Adarsh Kancharla | Non Executive Director | 2026 |
| Aluri Rao Srinivasa | Independent Non Exe. Director | 2026 |
| Anil Dhawan | Independent Non Exe. Director | 2026 |
| Santanu Mukherjee | Independent Non Exe. Director | 2026 |
| Sundari Raviprasad Pisupati | Independent Non Exe. Director | 2026 |
| Shreya Mitra | Company Sec. & Compli. Officer | 2026 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Medical and Healthcare Services | ₹0 Cr | — |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹10 | 150 | 102 | 102 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-07-21 | Dividend (3.5/- per share) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 279 | 0 | 0 | 26 | 15 | 320 |
| 2026 | 5 | 0 | 0 | 0 | 0 | 5 |
| 2026 | 268 | 0 | 0 | 26 | 9 | 304 |
Insider / Designated-Person Trades
30 recent disclosure(s)
Dr. Prashanth KDisposal · 10,000
Dr. Pranathi Subrahmanyam MaddiralaDisposal · 10,000
Dr. Pranathi Subrahmanyam MaddiralaDisposal · 5,000
Dr. Preetham Kumar PoddutoorDisposal · 3,500
Dr. Preetham Kumar PoddutoorDisposal · 15,600
Dr. Shruthi Reddy PoddutoorDisposal · 15,000
Substantial Acquisitions (SAST)
1 disclosure(s)
Market07/09/2023 · 20,88,635
Company Information
Incorporated1998
ChairmanRamesh Kancharla
AuditorS R Batliboi & Associates LLP
Investor Email[email protected]
📍 8-2-120/103/1 Survey No 403, Road No 2 Banjara Hills, Hyderabad, Telangana, 500034
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search